deltatrials
Completed OBSERVATIONAL NCT01377402

ARgentinean Risk Assessment Registry in ACS; the ARRA-RACS Study (ARRA-RACS)

ARgentinean Risk Assessment Registry in Acute Coronary Syndrome; the ARRA-RACS Study.

Sponsor: Helse Stavanger HF

Updated 13 times since 2017 Last updated: Mar 19, 2017 Started: Nov 30, 2005 Primary completion: Dec 31, 2010 Completion: Dec 31, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Chest Pain and Coronary Artery Disease and is currently completed. Helse Stavanger HF leads this study, which shows 13 recorded versions since 2005 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Jun 2017 · 5 months · monthly snapshot~Jun 2017 – ~Aug 2017 · 2 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2023 — Jul 2024 [monthly]

    Completed

  4. Dec 2022 — Jan 2023 [monthly]

    Completed

  5. Dec 2021 — Dec 2022 [monthly]

    Completed

Show 8 earlier versions
  1. Jan 2021 — Dec 2021 [monthly]

    Completed

  2. Nov 2020 — Jan 2021 [monthly]

    Completed

  3. Jun 2018 — Nov 2020 [monthly]

    Completed

  4. May 2018 — Jun 2018 [monthly]

    Completed

  5. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NANone

  6. Aug 2017 — Apr 2018 [monthly]

    Completed NA

  7. Jun 2017 — Aug 2017 [monthly]

    Completed NA

  8. Jan 2017 — Jun 2017 [monthly]

    Completed NA

    First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Helse Stavanger HF
  • Universidad Católica de Salta
Data source: Helse Stavanger HF

For direct contact, visit the study record on ClinicalTrials.gov .